Ray Y Hachem

12PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Predictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 20, 2026
Antimicrobial elution patterns correlate with antibacterial and antifungal activities of three antimicrobial central venous catheters in serum.

|Nov 26, 2025
Pediatric vs. Adult Invasive Aspergillosis in Cancer and Hematopoietic Transplant Patients: Insights from a Matched Cohort at a Tertiary Cancer Center.

Saliba Wehbe, Ramia Zakhour, Ray Hachem

|Feb 25, 2025
Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment: 30-Year Experience in Hematologic Malignancy Patients.

Hiba Dagher, Anne-Marie Chaftari, Andrea Haddad

|Feb 25, 2025
Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by Aspergillus terreus After the Introduction of Anti-Mold Azole Agents: A 30-Year Study at a Tertiary Cancer Center.

Ray Y Hachem, Hiba Dagher, Anne-Marie Chaftari

|Oct 26, 2024
Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia.

Hiba Dagher, Anne-Marie Chaftari, Ray Hachem

|Mar 13, 2024
Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients.

Andrea J Haddad, Ray Y Hachem, Mohamed Moussa

Pageof 2

Frequent Collaborators

6 joint publications

Anne-Marie Chaftari

6 joint publications

Hiba R Dagher

4 joint publications

Patrick Chaftari

2 joint publications

Bahgat Z Gerges